GGT5 and cancer: Differential expressions in the initial stage of cancer (CSI or CSI and CSII), such as for ADH1C, GGT5, NQO2, and SLC25A5 (Table 2 and Table 3, bolded), may indicate them as candidates for diagnostic biomarkers.